Horton D, Priebe W, Varela O
Carbohydr Res. 1985 Dec 1;144(2):305-15. doi: 10.1016/s0008-6215(00)90678-5.
Bromination of 3,4-di-O-acetyl-L-rhamnal (7) and subsequent glycosidic coupling under Koenigs-Knorr conditions with daunomycinone gave a mixture of three compounds having the beta-L-gluco (10), alpha-L-gluco (11), and alpha-L-manno (12) configurations. Analogous bromination of 3,4-di-O-acetyl-L-fucal (13) followed by coupling with daunomycinone gave a mixture of three glycosides having the beta-L-galacto (16), alpha-L-galacto (17), and alpha-L-talo (18) configurations. Chlorination of 7 and coupling with daunomycinone in the presence of silver triflate gave products having the alpha-L-gluco (21) and alpha-L-manno (22) configurations, whereas 13, under similar conditions, gave only one stereoisomeric product, that having the alpha-L-galacto (24) configuration. Compounds 12 and 22 showed high in vivo activity in the P-388 lymphocytic leukemia assay.
3,4 - 二 - O - 乙酰基 - L - 鼠李糖醛(7)的溴化反应,以及随后在柯尼希斯 - 克诺尔条件下与柔红霉素酮进行糖苷偶联反应,得到了三种具有β - L - 葡萄糖(10)、α - L - 葡萄糖(11)和α - L - 甘露糖(12)构型的化合物混合物。3,4 - 二 - O - 乙酰基 - L - 岩藻糖(13)进行类似的溴化反应,随后与柔红霉素酮偶联,得到了三种具有β - L - 半乳糖(16)、α - L - 半乳糖(17)和α - L - 塔罗糖(18)构型的糖苷混合物。7在三氟甲磺酸银存在下氯化并与柔红霉素酮偶联,得到了具有α - L - 葡萄糖(21)和α - L - 甘露糖(22)构型的产物,而13在类似条件下仅得到一种立体异构体产物,即具有α - L - 半乳糖(24)构型的产物。化合物12和22在P - 388淋巴细胞白血病试验中显示出高体内活性。